ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2016

Efficacy and Safety of Twice-Daily Glycopyrrolate Versus Placebo in Patients With COPD: The GEM2 Study.

Edward Kerwin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.